Fanning the Flames of Endoplasmic Reticulum (ER) Stress: Can Sphingolipid Metabolism Be Targeted to Enhance ER Stress–Associated Immunogenic Cell Death in Cancer?
Molecular Pharmacology · 2024
DOI: 10.1124/molpharm.123.000786 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Molecular Pharmacology, 2024. Verfasst von Jeremy A Hengst und 3 weiteren Autor:innen. Beteiligte Einrichtung: Departments of Pediatrics (J.A.H.) and Pharmacology (A.S., J.K.Y.), Pennsylvania State University College of Medicine, Hershey, Pennsylvania; and Dep…. Hauptthemen laut MEDLINE: Immunogenic Cell Death, Neoplasms. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 89 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Departments of Pediatrics (J.A.H.) and Pharmacology (A.S., J.K.Y.), Pennsylvania State University College of Medicine, Hershey, Pennsylvania; and Department of Drug Metabolism and Pharmacokinetics, National Center for A…
Zitieren
APA
Hengst, J. A., Nduwumwami, A. J., Sharma, A., & Yun, J. K. (2024). Fanning the Flames of Endoplasmic Reticulum (ER) Stress: Can Sphingolipid Metabolism Be Targeted to Enhance ER Stress–Associated Immunogenic Cell Death in Cancer?. Molecular Pharmacology. https://doi.org/10.1124/molpharm.123.000786
Vancouver
Hengst JA, Nduwumwami AJ, Sharma A, Yun JK. Fanning the Flames of Endoplasmic Reticulum (ER) Stress: Can Sphingolipid Metabolism Be Targeted to Enhance ER Stress–Associated Immunogenic Cell Death in Cancer?. Molecular Pharmacology. 2024. doi:10.1124/molpharm.123.000786
BibTeX
@article{Hengst2024,
author = {Hengst, Jeremy A and Nduwumwami, Asvelt J and Sharma, Arati and Yun, Jong K},
title = {Fanning the Flames of Endoplasmic Reticulum (ER) Stress: Can Sphingolipid Metabolism Be Targeted to Enhance ER Stress–Associated Immunogenic Cell Death in Cancer?},
journal = {Molecular Pharmacology},
year = {2024},
doi = {10.1124/molpharm.123.000786}
}
EUVIMED